Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 318

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1049	$PMCB News Article - PharmaCyte Biotech to Change	whytestocks	10/28/2019 9:15:42 AM
1048	The latest report, Biobanking	marketindustryreport	10/04/2019 3:36:12 AM
1047	$PMCB News Article - PharmaCyte Biotech Releases	whytestocks	09/25/2019 11:45:41 AM
1046	$PMCB News Article - PharmaCyte Biotech's	whytestocks	09/23/2019 9:15:45 AM
1045	$PMCB News Article - PharmaCyte Biotech Holding	whytestocks	09/11/2019 12:40:42 PM
1044	$PMCB News Article - PharmaCyte Biotech Confirms	whytestocks	08/28/2019 10:55:40 AM
1043	$PMCB News Article - PharmaCyte Biotech Releases	whytestocks	06/25/2019 9:30:42 AM
1042	Worldwide Pain Management Devices Market Research	marketindustryreport	06/20/2019 6:24:36 AM
1041	Market Industry Reports (MIR) has published a new	marketindustryreport	06/18/2019 8:18:30 AM
1040	Market Industry Reports (MIR) has published a new	marketindustryreport	06/10/2019 5:56:38 AM
1039	The global Disposable Syrin	marketindustryreport	06/06/2019 6:14:45 AM
1038	The next generati	dorotheapiper	05/30/2019 2:17:53 AM
1037	$PMCB < $0.051 znewcar (1)	PoemStone	02/04/2019 6:20:55 PM
1036	38.10% v14,192,781 c.058000 f1,126,904,510	znewcar1	02/04/2019 5:37:42 PM
1035	$PMCB call it	PoemStone	08/04/2018 12:13:19 PM
1034	$PMCB PharmaCyte Biotech Files Patent	Lets Roll	03/27/2018 9:42:13 AM
1033	$PMCB Increasing prevalence of cancer and rise in	trooperstocks	03/27/2018 8:42:25 AM
1032	$PMCB on alert! Take a look at the company	Lets Roll	03/22/2018 9:36:45 AM
1031	Check out the talented and experienced management	Lets Roll	03/21/2018 11:05:35 AM
1030	The daily chart does look ready for the next leg	Lets Roll	03/21/2018 10:02:39 AM
1029	http://pharmabypharmd.com/amicus-therapeutics-kno	Hiooletsgobio	02/07/2018 11:59:25 PM
1028	What is most interesting to me about the S-3 is	Triple9	09/16/2017 12:47:01 PM
1027	$PMCB has medical and scientific professionals	Triple9	09/14/2017 5:22:57 PM
1026	Pepper Hamilton LLP, one of the oldest law firms	Triple9	09/14/2017 5:21:44 PM
1025	Work on the master cell line started on June 5,	Triple9	09/14/2017 5:21:08 PM
1024	OK, we have the Imperial Room at the Fairmont	Triple9	07/21/2017 9:10:35 AM
1023	$PMCB great reading/ $PMCB PharmaCyte Biotech	mick	05/14/2017 10:42:31 AM
1022	THE WINNERS ARE $PMCB	mick	04/24/2017 10:42:13 AM
1021	$pmcb is stronger today than ever with	mick	04/19/2017 11:46:49 PM
1020	$PMCB / great read, dd, update	mick	04/19/2017 11:44:46 PM
1019	LAGUNA HILLS, Calif., April 18, 2017 (GLOBE (1)	mick	04/19/2017 4:36:27 PM
1018	LAGUNA HILLS, Calif., April 19, 2017 (GLOBE	mick	04/19/2017 4:25:24 PM
1017	PharmaCyte Biotech Receives the 2017 Pipelines	Triple9	04/19/2017 9:32:36 AM
1016	$PMCB	mick	04/17/2017 7:18:02 PM
1015	$PMCB voting 2393 / PharmaCyte Biotech PharmaCyte	mick	04/12/2017 10:21:44 AM
1014	$PMCB , GOOD MORNING	mick	04/12/2017 10:21:31 AM
1013	PharmaCyte Biotechs Cannabis Research Program	Triple9	04/10/2017 11:11:29 AM
1012	www.stockta.com/cgi-bin/candle.pl?cobrand=&symb=PM	mick	04/07/2017 4:48:45 PM
1011	$PMCB	mick	04/07/2017 4:45:24 PM
1010	$PMCB	mick	04/07/2017 3:19:17 PM
1009	$PMCB ON VOTING $PMCB 943	mick	04/07/2017 12:14:07 PM
1008	$PMCB VOTE FOR FAVORITE BIOTECH COMPANY $PMCB	mick	04/05/2017 4:41:59 PM
1007	$PMCB did ya vote ?????	mick	04/05/2017 4:39:09 PM
1006	$PMCB DID YOU VOTE ?????	mick	04/05/2017 4:38:14 PM
1005	PharmaCyte Biotech Appoints Dr. Mark Rabe	Triple9	04/03/2017 9:26:39 AM
1004	$PMCB News! First Ever Cannabis-Based ETF to	mick	03/25/2017 7:20:33 PM
1003	$PMCB PharmaCyte Biotech is currently developing	mick	03/25/2017 7:19:28 PM
1002	$PMCB Part 1 PharmaCyte Biotech Medical &	mick	03/25/2017 7:18:30 PM
1001	$PMCB Part 2 PharmaCyte Biotech Medical &	mick	03/25/2017 7:17:55 PM
1000	$PMCB Part 3 PharmaCyte Biotech Medical &	mick	03/25/2017 7:17:21 PM

Newer

Older

Recent Articles

• OnKure Therapeutics Schedules Investor Call for Key Updates
• Exciting Breakthroughs in Breast Cancer Treatment by Arvinas
• Steel Keg Association Promotes Reusable Kegs Amid Leadership Change
• Investors Urged to Join Humacyte, Inc. Class Action Lawsuit
• Minnesota's Cannabis Lottery Delayed Amid Legal Challenges
• Kohl's Welcomes Ashley Buchanan as CEO to Foster Growth
• State Street's $2.25 Billion Debt: Fostering Inclusion in Finance
• Faraday Future Reinvents Its Stock Symbol to Emphasize AI
• Golub Capital BDC Introduces Major $150 Million Note Offering
• HPH Sees Board Changes Amid Strategic Transformation
• Eastman Kodak's Strategic Pension Plan Move and Market Impact
• HPH Announces Leadership Transition and Future Focus
• SpaceX to Launch NASA's Dragonfly Mission to Titan
• Clairvest's New Partnership with Redstone Food Group
• Automotive Properties REIT Acquires Key Montreal Rental Properties
• Tim Draper Enthusiastically Predicts Bitcoin's Striking Rise
• Hennessy Advisors' ESG ETF to Transfer Listings to Nasdaq
• Agora, Inc. Sees Strategic Shifts Amid Financial Adjustments
• Hesai Group Announces Impressive Q3 2024 Financial Growth
• Creative Global Technology Holdings' Upcoming IPO Details
• Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
• Analyzing Woodward's Q4 Earnings and Future Outlook
• Blue Bird's Financial Performance in the Latest Earnings Report
• Central Garden & Pet Reports Strong Q4 Earnings Performance
• Central Garden & Pet's Strong Q4 Earnings Highlights
• Enanta Pharma's Earnings Report Highlights for Investors in 2024
• Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
• Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights